DE2506908A1 - Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel - Google Patents

Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Info

Publication number
DE2506908A1
DE2506908A1 DE19752506908 DE2506908A DE2506908A1 DE 2506908 A1 DE2506908 A1 DE 2506908A1 DE 19752506908 DE19752506908 DE 19752506908 DE 2506908 A DE2506908 A DE 2506908A DE 2506908 A1 DE2506908 A1 DE 2506908A1
Authority
DE
Germany
Prior art keywords
group
carbon atoms
chain
straight
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752506908
Other languages
German (de)
English (en)
Inventor
Ralph L Brattsand
Karl G Claeson
Stig I Gustavsson
Helge G Oresten
Lars-Inge Wickstroem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASTRA BOFORS NOBELPHARMA AB
Original Assignee
ASTRA BOFORS NOBELPHARMA AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASTRA BOFORS NOBELPHARMA AB filed Critical ASTRA BOFORS NOBELPHARMA AB
Publication of DE2506908A1 publication Critical patent/DE2506908A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752506908 1974-03-06 1975-02-19 Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel Pending DE2506908A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7402962A SE378815B (cs) 1974-03-06 1974-03-06

Publications (1)

Publication Number Publication Date
DE2506908A1 true DE2506908A1 (de) 1975-09-18

Family

ID=20320427

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752506908 Pending DE2506908A1 (de) 1974-03-06 1975-02-19 Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Country Status (10)

Country Link
JP (1) JPS50117777A (cs)
BE (1) BE826349A (cs)
DE (1) DE2506908A1 (cs)
DK (1) DK88575A (cs)
FI (1) FI750512A (cs)
FR (1) FR2262987A1 (cs)
LU (1) LU71983A1 (cs)
NL (1) NL7502688A (cs)
NO (1) NO750733L (cs)
SE (1) SE378815B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252957A (en) * 1978-03-09 1981-02-24 Pfizer Inc. Heterocyclylcarbonyl derivatives of urea

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252957A (en) * 1978-03-09 1981-02-24 Pfizer Inc. Heterocyclylcarbonyl derivatives of urea

Also Published As

Publication number Publication date
JPS50117777A (cs) 1975-09-16
DK88575A (cs) 1975-09-07
FR2262987A1 (cs) 1975-10-03
LU71983A1 (cs) 1976-02-04
BE826349A (fr) 1975-09-08
FI750512A (cs) 1975-09-07
SE378815B (cs) 1975-09-15
SE7402962L (cs) 1975-09-08
NO750733L (cs) 1975-09-09
NL7502688A (nl) 1975-09-09

Similar Documents

Publication Publication Date Title
DE3143219C2 (cs)
DE2445584C3 (de) L- bzw. DL-2-Methyl-3- (3', 4'-dihydroxyphenyl)-alanin-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
EP0193056B1 (de) Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
DE2822789C2 (de) N-Acetyl-DL-methionin-(p-acetylaminophenyl)-ester, Verfahren zu seiner Herstellung und seine Verwendung
DE3751036T2 (de) Durch Carnitin dirigierte pharmazeutische Substanzen und ihre Verwendung zur Herstellung eines Arzneimittels zur Behandlung von Muskelerkrankungen.
DE68910211T2 (de) Estramustin-ester.
DE2332837A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3212736A1 (de) Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE2924691C2 (cs)
DE2716402A1 (de) 7-(2,3-dihydroxypropyl)-1,3-di-n- propylxanthin, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DE3873210T2 (de) Verwendung von benzylpyridin-derivaten zur herstellung eines arzneimittels zur behandlung der demenz.
EP0163984A2 (de) Dihydropyridinkombinationspräparate und Verfahren zu ihrer Herstellung
DE69023045T2 (de) Carboxamidderivate.
DE2506908A1 (de) Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2322561A1 (de) Trisubstituierte imidazole
DE2605243A1 (de) Pyrazolessigsaeurehaltiges arzneimittel
DE2038628B2 (de) N,N'-Di(carboxyalkyl)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung
DE1906322A1 (de) Neue alpha-Alkyl-5-hydroxytryptophanester
DE2049115C3 (de) Verwendung von Calcium-5-butylpicolinat und/oder Calcium-5-pentylpicolinat bei der Bekämpfung des Parkinsonismus mit 3-(3,4-Dihydroxyphenyl)-L-alanin (L-Dopa)
DE2164988C3 (de) 2,2-Diphenylcyclopropancarbonsäureesterderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE1620177B2 (de) N-(2-Hydroxyäthyl) -piperazinocarboxymethyl-te tr acy elin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1618042C (cs)
DE2551591A1 (de) 4-(4-diphenylyl)-butylamine und pharmazeutische zusammensetzungen
DE2005255B2 (de) Verwendung von Ca-5-burylpicolinat und/oder Ca-5-pentylpicoHnat zur Herstellung eines blutdrucksenkenden Arzneimittels